19:50 EST eFFECTOR Therapeutics trading halted, news pending
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on EFTR:
- eFFECTOR Therapeutics to Host Virtual Investor R&D Day on January 24, 2024
- eFfector Therapeutics board approves 1-for-25 reverse stock split
- eFFECTOR Therapeutics Announces New Positive Interim Data from Dose Escalation and Phase 2 Expansion Cohorts of Zotatifin in ER+ Metastatic Breast Cancer Patients
- eFfector announces interim data from Phase 2 expansion cohorts of zotatifin
- eFFECTOR Therapeutics receives Fast Track Designation for zotatifin combination